 | Bruce C. Baguley, David J. Kerr - 2001 - 397 páginas
...Caputo, R., Bianco, R., Damiano, V., Pomatico, G., De Placido, S., Bianco, AR, and Tortora, G. (2000). Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin. Cancer... | |
 | Richard R. Barakat, Michael W Bevers, David M. Gershenson, William J. Hoskins - 2002 - 468 páginas
...Chabner B, Longo D (eds). Cancer Chemotherapy and Biotherapy. Philadelphia: Lippincott-Raven, 1996. Ciardiello F, Caputo R, Bianco R et al, Antitumor...cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptorselective tyrosine kinase inhibitor. Clin Cancer... | |
 | Vincent T. DeVita, Samuel Hellman, Steven A. Rosenberg - 2003 - 412 páginas
...tyrosine kinase inhibitors as anticancer agents. Drugs 2000:60:25-32 [discussion 41-22]. 50. Ciardiello E Caputo R, Bianco R et al. Antitumor effect and potentiation...cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer... | |
 | Pierre-Alain Clavien, Yuman Fong - 2004 - 534 páginas
...progression from reversible to irreversible inhibitors. Pharmacology & Therapeutics 1999;82(2-3):207-218. 33. Ciardiello F, Caputo R, Bianco R, et al. Antitumor...cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clinical... | |
 | Graham Carpenter - 2004 - 166 páginas
...F. Ciardiello, R. Caputo, R. Bianco, V. Damiano, G. Pomatico, S. De Placido, AR Bianco, G. Tortora, Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD- 1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor, Clin. Cancer... | |
 | Vincent T. DeVita, Jr., Samuel Hellman, Steven A. Rosenberg - 2004 - 380 páginas
...and transactivation by insulin-like growth factor receptor. J Biol Chem 2002;277:27643-27650. 141. Ciardiello F, Caputo R, Bianco R et al. Antitumor...cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer... | |
 | Julia D. Martinez - 2005 - 344 páginas
...factor receptor tyrosine kinases inhibitors as anticancer agents. Drugs. 2000; 60(Suppl l):25-32. [135] Ciardiello F, Caputo R Bianco R, et al. Antitumor...cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor. Clin Cancer Res. 2000; 6: 2053-2063.... | |
 | John N. Lucas - 2004 - 266 páginas
...1997; 16: A1108 [100] Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S. Antitumour effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer... | |
 | William J. LaRochelle, Richard A. Shimkets - 2007 - 750 páginas
...epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res 2001; 7:1459-1465. 25. Ciardiello F, Caputo R, Bianco R, et al. Antitumor...cytotoxic drugs activity in human cancer cells by ZD 1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer... | |
 | Daniel D. Von Hoff, Douglas Brian Evans, Ralph H. Hruban - 2005 - 866 páginas
...Epidermal growth factor receptor-targeted therapy for pancreatic cancer. Semin Oncol. 2002;29:31-37. 24. Ciardiello F, Caputo R, Bianco R, et al. Antitumor...cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer... | |
| |
Ciardiello F, Caputo R, Bianco R, et al. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer Res. 
